Accordingly, significantly decreased plasma levels of inflammatory IL-1β, increased MMP-2 activity and reduced accumulation of collagen fibers were observed in the atrial walls of BM-MSC-treated OSA rats [36]. The gene discussed is IL1B; the disease is obstructive sleep apnea syndrome.